Last $4.42 USD
Change Today +0.07 / 1.61%
Volume 54.1K
XNPT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 12:35 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William J. Dower Ph.D.

Co-Founder and Vice President of Discovery Biology, Xenoport, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

66--

Background*

William J. Dower, Ph.D. has been Vice President of Discovery Biology of Xenoport Inc. since 1999. Dr. Dower is one of Xenoport Inc.'s founders and has been Xenoport Inc.'s Vice President of discovery biology since 1999. From 1989 to 1999, he held various positions at Affymax Research Institute, the most recent of which was senior director of molecular biology. Prior to Affymax Research Institute, Dr. Dower held the position of senior research biochemist at Bio-Rad ...

Read Full Background

Corporate Headquarters*

3410 Central Expressway
Santa Clara, California 95051

United States

Phone: 408-616-7200
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
University of California - San Diego
BA
University of California - San Diego

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XNPT:US $4.42 USD +0.07

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael S. Anderson Chief Executive Officer and Director
Flamel Technologies SA
--
Jeffrey B. Davis Chief Executive Officer, President, Acting Chief Financial Officer, Principal Accounting Officer, Secretary, Treasurer and Director
Access Pharmaceuticals Inc.
$503.0K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
$739.3K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENOPORT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.